Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice

Regorafenib has been demonstrated in our previous study to trigger apoptosis through suppression of extracellular signal-regulated kinase (ERK)/nuclear factor-κB (NF-κB) activation in hepatocellular carcinoma (HCC) SK-Hep1 cells in vitro. However, the effect of regorafenib on NF-κB-modulated tumor p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biosci Rep
Autors principals: Weng, Mao-Chi, Wang, Mei-Hui, Tsai, Jai-Jen, Kuo, Yu-Cheng, Liu, Yu-Chang, Hsu, Fei-Ting, Wang, Hsin-Ell
Format: Artigo
Idioma:Inglês
Publicat: Portland Press Ltd. 2018
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5938429/
https://ncbi.nlm.nih.gov/pubmed/29535278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20171264
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars